J. Ip

发表

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Douglas L Packer, Daniel B Mark, D. Mark, 2005, The New England journal of medicine.

Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial.

A. Camm, E. Toft, D. Wyse, 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Prophylactic Defibrillator Implantation in Patients With Nonischemic Dilated Cardiomyopathy

A. Khasnis, J. Ip, I. S. Virk, 2004 .

Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation.

V. Fuster, J. Badimón, L. Badimón, 1990, Journal of the American College of Cardiology.

Beyond MADIT

J. Ip, Peerawut Deeprasertkul, A. Sharma, 2013 .

Impact of atrial prevention pacing on atrial fibrillation burden: primary results of the Study of Atrial Fibrillation Reduction (SAFARI) trial.

Ellen Hoffmann, Michael R Gold, M. Gold, 2009, Heart rhythm.

Evolution of Curative Therapies For Atrial Fibrillation

A. Khasnis, K. Jongnarangsin, R. Thakur, 2004, Indian pacing and electrophysiology journal.

Antithrombotic Therapy in Cardiovascular Diseases

V. Fuster, L. Badimón, J. Ip, 1991 .

Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study.

G. Lip, J. Halperin, P. Rothwell, 2009, American Heart Journal.

Importance of experimental models for the development of clinical trials on thromboatherosclerosis.

J. Badimón, L. Badimón, J. Chesebro, 1991, Circulation.

Myocardial preservation during ischemia and reperfusion.

R. Levin, J. Ip, 1988, American heart journal.

Preservation of myocardial high-energy phosphates with vagal stimulation and hypothermic cardioplegia.

R. Karp, J. Levett, J. Ip, 1986, The Annals of thoracic surgery.

Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

D. Mark, K. Lee, A. Hellkamp, 2007, American heart journal.

Arrhythmias, Sudden Death and Syncope in Elders

R. Thakur, J. Ip, C. Shah, 1997 .

Preservation of myocardial high energy phosphates during cardioplegic arrest with nifedipine.

R. Karp, J. Levett, J. Ip, 1988, The Journal of surgical research.

Abstract 15956: Leadless Cardiac Pacemaker: Does Anatomical Position at Implant Affect Long Term Electrical Performance?

D. Exner, J. Ip, I. Niazi, 2016 .

Exploration of the atherosclerotic plaque.

V. Fuster, J. Chesebro, J. Ip, 1990, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

The learning curve associated with the implantation of the Nanostim leadless pacemaker

P. Neužil, V. Reddy, D. Exner, 2018, Journal of interventional cardiac electrophysiology.

A worldwide experience of the management of battery failures and chronic device retrieval of the Nanostim leadless pacemaker.

Dhanunjaya R. Lakkireddy, P. Neužil, K. Aonuma, 2017, Heart rhythm.

Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker.

Vivek Y. Reddy, Paul Andrew Friedman, N. A. Mark Estes, 2015, The New England journal of medicine.

Medical aspects of acute aortic dissection.

J. Ip, V. Fuster, 1991, Seminars in thoracic and cardiovascular surgery.

The signal averaged ECG in patients with sustained ventricular tachycardia in the setting of coronary artery disease

S. Winters, J. A. Gomes, J. Ip, 1993 .

Use of the signal averaged ECG in the management of nonsustained ventricular tachycardia

S. Winters, J. A. Gomes, J. Ip, 1993 .

Determinants of induction of ventricular tachycardia in nonsustained ventricular tachycardia after myocardial infarction and the usefulness of the signal-averaged electrocardiogram.

S. Winters, K. Daniels, J. A. Gomes, 1993, The American journal of cardiology.

Tweaking the signal-averaged electrocardiogram in search of improved predictive accuracy.

S. Winters, J. A. Gomes, J. Ip, 1992, Journal of the American College of Cardiology.

Signal Averaging of the Surface QRS Complex: Practical Applications

S. Winters, J. A. Gomes, J. Ip, 1991 .

Intraventricular conduction disturbances in patients with acute myocardial infarction : indications for a temporary pacemaker

D. Tepper, J. Ip, E. Korban, 1990 .

Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea

A. Khasnis, J. Ip, I. S. Virk, 2004 .

Programming Antitachycardia Pacing for Primary Prevention in Patients With Implantable Cardioverter Defibrillators: Results From the PROVE Trial

A. Massumi, J. Ip, M. Razavi, 2010, Journal of cardiovascular electrophysiology.

Risk stratification post myocardial infarction identification of patients at high risk of sudden cardiac death

J. A. Gomes, S. Winters, J. Ip, 1993 .

Subpectoral Implantation of ICD Generators: Long‐Term Follow‐Up

J. A. Gomes, D. Mehta, R. Thakur, 1995, Pacing and clinical electrophysiology : PACE.

Statin Therapy Is Associated With Improved Survival in Ischemic and Non‐Ischemic Heart Failure

A. Khasnis, J. Ip, S. Kantipudi, 2004 .

Thrombosis, antithrombotic therapy and sudden death

V. Fuster, J. Ip, 1991 .

Interactions between blood and coronary arterial wall

V. Fuster, L. Badimón, J. Chesebro, 1989 .

A Useful Marker During Ablation

R. Thakur, J. Ip, C. Shah, 1997, Pacing and clinical electrophysiology : PACE.

Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT).

G. Lip, J. Halperin, A. Waldo, 2016, The American journal of cardiology.

Abstract 2113: T-Wave Alternans SCD HeFT Study: Primary Endpoint Analysis

M. Gold, S. McNulty, G. Bardy, 2006 .

Determinants of Pace‐Terminable Ventricular Tachycardia: Implications for Implantable Antitachycardia Devices

D. Tepper, S. Winters, J. Ip, 1991, Pacing and clinical electrophysiology : PACE.

The Debate Over Anticoagulation in Patients With Heart Failure

D. Tepper, J. Ip, I. S. Virk, 2006 .

Surveillance of AF recurrence post-surgical AF ablation using implantable cardiac monitor

J. Ip, Maria Viqar-Syed, D. Gandhi, 2011, Journal of Interventional Cardiac Electrophysiology.

The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty.

V. Fuster, J. Badimón, L. Badimón, 1991, Journal of the American College of Cardiology.

Management of Mobile Right Atrial Thrombi: A Therapeutic Dilemma

G. Guiraudon, R. Thakur, J. Ip, 1996, Journal of cardiac surgery.

Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices.

G. Lip, J. Halperin, A. Waldo, 2015, European heart journal.

Anticoagulation Therapy for Atrial Fibrillation in Patients with Implanted Cardiac Arrhythmia Devices

J. Halperin, J. Ip, 2011 .

A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT).

J. Messenger, S. Kalbfleisch, J. Mackall, 2003, Journal of the American College of Cardiology.

Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation: A Phase 3, Randomized, Placebo-Controlled Trial

A. Camm, E. Toft, A. Camm, 2008, Circulation.

A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation.

I. Stiell, B. Rowe, J. Lee, 2004, Journal of the American College of Cardiology.

Accuracy of arrhythmia detection in implantable cardiac monitors: A prospective randomized clinical trial comparing Reveal LINQ and Confirm Rx

J. Ip, M. Castellani, R. Ip, 2020, Pacing and clinical electrophysiology : PACE.

Oral d,lsotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study☆

S. Lansman, D. Mehta, J. A. Gomes, 1999 .

Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study.

S. Lansman, D. Mehta, J. A. Gomes, 1999, Journal of the American College of Cardiology.

Comparative study of acute and mid-term complications with leadless and transvenous cardiac pacemakers.

V. Reddy, D. Exner, K. Davis, 2018, Heart rhythm.

Relationship between atrial tachyarrhythmias and symptoms.

S. Saksena, S. Strickberger, J. Ip, 2005, Heart rhythm.

Post myocardial infarction stratification and the signal-averaged electrocardiogram.

S. Winters, J. A. Gomes, J. Ip, 1993, Progress in cardiovascular diseases.

Cardiac arrhythmias in the elderly.

D. Tresch, R. Thakur, J. Ip, 2002, Indian heart journal.

The porcine model for the understanding of thrombogenesis and atherogenesis.

J. Badimón, L. Badimón, J. Chesebro, 1991, Mayo Clinic proceedings.

Role of Microvolt T-Wave Alternans in Assessment of Arrhythmia Vulnerability Among Patients With Heart Failure and Systolic Dysfunction: Primary Results From the T-Wave Alternans Sudden Cardiac Death in Heart Failure Trial Substudy

D. Mark, M. Gold, O. Costantini, 2008, Circulation.

The Impact of Atrial Prevention and Termination Therapies on Atrial Tachyarrhythmia Burden in Patients Receiving a Dual-Chamber Defibrillator for Ventricular Arrhythmias

M. Jazayeri, P. Friedman, B. Olshansky, 2004, Journal of Interventional Cardiac Electrophysiology.

The Role of Parasympathetic Modulation of the Reentrant Arrhythmic Substrate in the Genesis of Sustained Ventricular Tachycardia

J. A. Gomes, J. Ip, K. Suh, 1994, Pacing and clinical electrophysiology : PACE.

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

G. Breithardt, H. Crijns, P. Mclaughlin, 2016, Journal of the American Heart Association.

Subpectoral implantation of cardioverter-defibrillator combined with a nonepicardial lead system: preliminary experience with a novel approach.

J. A. Gomes, D. Mehta, J. Ip, 1993, The American journal of cardiology.

Data Transmission Delay in Medtronic Reveal LINQTM Implantable Cardiac Monitor: Clinical Experience in 520 Patients

J. Ip, R. Chokesuwattanaskul, John H. Ip, 2019, Journal of Biomedical Science and Engineering.

A Preventable Pacemaker Problem

G. Klein, R. Thakur, J. Ip, 1996, Pacing and clinical electrophysiology : PACE.

Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial

Geral G. Greer, Miguel Angel Hervas, Tjeerd J. Romer, 2023, The Lancet.

Evolution of Curative Therapies For Atrial Fibrillation Review

A. Khasnis, R. Thakur, J. Ip, 2003 .

Circadian Variation in Sudden Cardiac Death: Effects of Age, Sex, and Initial Cardiac Rhythm

T. Aufderheide, R. Hoffmann, D. Tresch, 1996 .

NonPharmacologic Management of Atrial Fibrillation Using the Dynamic Atrial Overdrive Algorithm

P. Levine, J. Ip, M. Damen, 2010 .

AB24-2: Statin therapy was associated with reduced atrial fibrillation and flutter in heart failure patients in SCD-HeFT

D. Mark, A. Hellkamp, G. Bardy, 2006 .

Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial

Geral G. Greer, Miguel Angel Hervas, Tjeerd J. Romer, 2023, The Lancet.

Predictors of long-term survival in patients with malignant ventricular arrhythmias.

S L Winters, J A Gomes, D. Mehta, 1997, The American journal of cardiology.

Implantable Cardioverter Defibrillator Therapy in Patients with Ischemic or Non-Ischemic Cardiomyopathy and Nonsustained Ventricular Tachycardia

A. Khasnis, Rudolph F. Evonich, J. Gardiner, 2004, Journal of Interventional Cardiac Electrophysiology.

Thrombosis and accelerated atherosclerosis in coronary bypass surgery and restenosis after percutaneous transluminal coronary angioplasty: implications for therapy

V. Fuster, J. Badimón, L. Badimón, 1990 .